These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 565382)

  • 41. Ixodes dammini: salivary anti-complement activity.
    Ribeiro JM
    Exp Parasitol; 1987 Dec; 64(3):347-53. PubMed ID: 3119364
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of Ross River virus with the complement system.
    Aaskov JG; Hadding U; Bitter-Suermann D
    J Gen Virol; 1985 Jan; 66 ( Pt 1)():121-9. PubMed ID: 2981956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary structure of human complement component C2. Homology to two unrelated protein families.
    Bentley DR
    Biochem J; 1986 Oct; 239(2):339-45. PubMed ID: 2949737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection and analysis of inborn and acquired complement abnormalities.
    Gewurz AT; Lint TF; Imherr SM; Garber SS; Gewurz H
    Clin Immunol Immunopathol; 1982 May; 23(2):297-311. PubMed ID: 6286195
    [No Abstract]   [Full Text] [Related]  

  • 45. Congenital deficiency of C2 and factor B.
    Raum D; Glass D; Agnello V; Schur P; Alper CA
    N Engl J Med; 1978 Dec; 299(23):1313. PubMed ID: 714103
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of ethyleneglycoltetraacetic acid and its magnesium salt as reagents for studying alternative complement pathway function.
    Fine DP
    Infect Immun; 1977 Apr; 16(1):124-8. PubMed ID: 406201
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional assay of the alternative complement pathway of rat serum.
    Coonrod JD; Jenkins SD
    J Immunol Methods; 1979; 31(3-4):291-301. PubMed ID: 42660
    [No Abstract]   [Full Text] [Related]  

  • 48. Activation of the complement cascade by a purified component of pigeon dropping extract (PDE1).
    Marx JJ; Boren MN; Moore VL
    Clin Immunol Immunopathol; 1977 Nov; 8(3):487-93. PubMed ID: 912946
    [No Abstract]   [Full Text] [Related]  

  • 49. Recurrent pyogenic infections in individuals with absence of the second component of complement.
    Sampson HA; Walchner AM; Baker PJ
    J Clin Immunol; 1982 Jan; 2(1):39-45. PubMed ID: 6980226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunity in lamprey. III. Occurrence of the complement-like activity.
    Fujii T; Murakawa S
    Dev Comp Immunol; 1981; 5(2):251-9. PubMed ID: 6786926
    [No Abstract]   [Full Text] [Related]  

  • 51. Immunoadherence and complement in cancer-bearing mice.
    Porta C; Villa ML; Clerici E
    Br J Cancer; 1978 Jan; 37(1):23-7. PubMed ID: 619956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypocomplementemia in anorexia nervosa.
    Kim Y; Michael AF
    J Pediatr; 1975 Oct; 87(4):582-5. PubMed ID: 1159589
    [No Abstract]   [Full Text] [Related]  

  • 53. The second component of human complement (C2): quantitative molecular analysis of its reactions in immune hemolysis.
    Cooper NR; Polley MJ; Müller-Eberhard HJ
    Immunochemistry; 1970 Apr; 7(4):341-56. PubMed ID: 5464477
    [No Abstract]   [Full Text] [Related]  

  • 54. Disseminated gonococcal infection associated with deficiency of the second component of complement.
    McWhinney PH; Langhorne P; Love WC; Whaley K
    Postgrad Med J; 1991 Mar; 67(785):297-8. PubMed ID: 2062782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Simple method for preparing the cellular intermediate EAC14, and its use for estimation of the second component of complement.
    Asghar SS; Out J; van der Helm HJ
    Clin Chem; 1986 Apr; 32(4):678-9. PubMed ID: 3955817
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A method of preparing a reagent for assessing the activity of the second component and factor B of the complement system].
    Antashev AV; Shkurko VI
    Klin Lab Diagn; 1996; (3):33-4. PubMed ID: 8925213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A hemolytic assay for clinical investigation of human C2.
    Joisel F; Leroux-Nicollet I; Lebreton JP; Fontaine M
    J Immunol Methods; 1983 Apr; 59(2):229-35. PubMed ID: 6841978
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enzymatic activity of the second component of complement.
    Cooper NR
    Biochemistry; 1975 Sep; 14(19):4245-51. PubMed ID: 241376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The study of the human complement cascade of proteolysis as a target of laser irradiation].
    Galebskaia LV; Andreeva LA; Solovtsova IL; Solov'eva MA; Petrishchev NN
    Biomed Khim; 2009; 55(1):68-72. PubMed ID: 19351035
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A simple method for producing monospecific antiserum to beta 1 -C fraction (third component of complement) of human serum.
    Malaviya AN; Batra B; Vaishnava S
    Indian J Med Res; 1972 Mar; 60(3):416-8. PubMed ID: 4659921
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.